Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-01-09

FDA Approved: FLUOXETINE — Supplemental Application (Vensun Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for fluoxetine hydrochloride from Vensun Pharmaceuticals, Inc., granting approval of a generic fluoxetine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluoxetine hydrochloride (generic) (Fluoxetine hydrochloride)

Snippet

SUPPL AP for FLUOXETINE (FLUOXETINE HYDROCHLORIDE)